{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/157458379"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "It has been exceedingly easy for us to strike up collaborations with both industry and FDA, albeit for somewhat different reasons.FDA is exceedingly interested in novel ways of evaluating the safety and efficacy of the products that they see.We collaborate with industry on sort of two levels." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "raps.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/358190690"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/157458379"] } } }
